Application Note

Manufacturing of hiPSC-Derived Cardiomyocytes

Format: PDF file | Document type: Application Note

Manufacturing of hiPSC-Derived Cardiomyocytes

Related categories: Bioreactors

Effective drug discovery and development relies on the availability of predictive preclinical model systems. Technologies based on human induced pluripotent stem cells (hiPSC) hold great promise to overcome this challenge.

In this application note researchers from Ncardia® show how they developed a bioprocess for the large-scale manufacturing of cardiomyocytes derived from a variety of healthy and diseased hiPSC lines for implementation into their DiscoverHIT platform.

Related resources from Eppendorf for Bioprocess – Solutions that grow with you

Show more

Supplier info centre